Crespi Francesco
Biology Department, Neurosciences CEDD GlaxoSmithKline, Medicines Research Centre, via Fleming 4, 37135 Verona, Italy.
Open Neurol J. 2010 May 21;4:5-14. doi: 10.2174/1874205X01004010005.
Reduced activity of CNS serotonin is reported in unipolar depression and serotonin is the major target of recent antidepressant drugs. However, an acute depletion of serotonin in healthy individuals does not induce depressive symptoms suggesting that depression does not correlate with the serotonin system only. Neuronal plasticity (structural adaptation of neurons to functional requirements) includes synthesis of microtubular proteins such as tyrosinated isoform of alpha-tubulin and presence of serotonin as regulator of synaptogenesis. In depression neuronal plasticity is modified.HERE, IN RATS SUBMITTED TO A BEHAVIOURAL TEST WIDELY USED TO PREDICT THE EFFICACY OF ANTIDEPRESSANT DRUGS (FORCED SWIMMING TEST: FST) a significant decrease of both cerebral tyrosinated alpha-tubulin expression and serotonin levels is monitored. Moreover, treatment with para-chlorophenylalanine (PCPA, compound that specifically depletes brain serotonin) but not alpha-methyl para tyrosine (alpha-MPT, compound that blocks synthesis of catechols: chemicals also implicated in depression) significantly reduced tyrosinated alpha-tubulin. Thus, a direct relationship between serotonin and tyrosinated alpha-tubulin appears to be present both in "physiological" and in "pathological" states. In addition, data obtained in animals submitted to FST and/or treated with the selective serotonin reuptake inhibitor (SSRI) fluoxetine further support the interrelationship between central serotonin and cytoskeleton. These data propose that direct relationship between serotonin and tyrosinated alpha-tubulin could be considered within the mechanism(s) involved in the pathogenesis of depression.
据报道,单相抑郁症患者中枢神经系统5-羟色胺活性降低,5-羟色胺是近期抗抑郁药物的主要作用靶点。然而,健康个体急性耗尽5-羟色胺并不会诱发抑郁症状,这表明抑郁症并非仅与5-羟色胺系统相关。神经元可塑性(神经元根据功能需求进行的结构适应性变化)包括微管蛋白的合成,如α-微管蛋白的酪氨酸化异构体,以及5-羟色胺作为突触形成调节因子的存在。在抑郁症中,神经元可塑性会发生改变。在此,在接受广泛用于预测抗抑郁药物疗效的行为测试(强迫游泳试验:FST)的大鼠中,监测到脑内酪氨酸化α-微管蛋白表达和5-羟色胺水平均显著降低。此外,用对氯苯丙氨酸(PCPA,一种特异性耗尽脑内5-羟色胺的化合物)而非α-甲基对酪氨酸(α-MPT,一种阻断儿茶酚合成的化合物:儿茶酚也是与抑郁症相关的化学物质)处理,可显著降低酪氨酸化α-微管蛋白水平。因此,5-羟色胺与酪氨酸化α-微管蛋白之间的直接关系似乎在“生理”和“病理”状态下均存在。此外,在接受FST和/或用选择性5-羟色胺再摄取抑制剂(SSRI)氟西汀处理的动物中获得的数据,进一步支持了中枢5-羟色胺与细胞骨架之间的相互关系。这些数据表明,5-羟色胺与酪氨酸化α-微管蛋白之间的直接关系可在抑郁症发病机制所涉及的机制中加以考虑。